• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-129-3p通过抑制CP110来控制转移性前列腺癌细胞中的中心体数量。

miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.

作者信息

Bijnsdorp Irene V, Hodzic Jasmina, Lagerweij Tonny, Westerman Bart, Krijgsman Oscar, Broeke Jurjen, Verweij Frederik, Nilsson R Jonas A, Rozendaal Lawrence, van Beusechem Victor W, van Moorselaar Jeroen A, Wurdinger Thomas, Geldof Albert A

机构信息

Department of Urology, VU University Medical Center, Amsterdam, The Netherlands.

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Oncotarget. 2016 Mar 29;7(13):16676-87. doi: 10.18632/oncotarget.7572.

DOI:10.18632/oncotarget.7572
PMID:26918338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4941343/
Abstract

The centrosome plays a key role in cancer invasion and metastasis. However, it is unclear how abnormal centrosome numbers are regulated when prostate cancer (PCa) cells become metastatic. CP110 was previously described for its contribution of centrosome amplification (CA) and early development of aggressive cell behaviour. However its regulation in metastatic cells remains unclear. Here we identified miR-129-3p as a novel metastatic microRNA. CP110 was identified as its target protein. In PCa cells that have metastatic capacity, CP110 expression was repressed by miR-129-3p. High miR-129-3p expression levels increased cell invasion, while increasing CP110 levels decreased cell invasion. Overexpression of CP110 in metastatic PCa cells resulted in a decrease in the number of metastasis. In tissues of PCa patients, low CP110 and high miR-129-3p expression levels correlated with metastasis, but not with the expression of genes related to EMT. Furthermore, overexpression of CP110 in metastatic PCa cells resulted in excessive-CA (E-CA), and a change in F-actin distribution which is in agreement with their reduced metastatic capacity. Our data demonstrate that miR-129-3p functions as a CA gatekeeper in metastatic PCa cells by maintaining pro-metastatic centrosome amplification (CA) and preventing anti-metastatic E-CA.

摘要

中心体在癌症侵袭和转移中起关键作用。然而,尚不清楚前列腺癌细胞发生转移时异常的中心体数量是如何被调控的。CP110此前被描述为在中心体扩增(CA)及侵袭性细胞行为早期发展中发挥作用。然而其在转移细胞中的调控机制仍不清楚。在此,我们鉴定出miR-129-3p是一种新型的转移相关微小RNA。CP110被确定为其靶蛋白。在具有转移能力的前列腺癌细胞中,CP110的表达受到miR-129-3p的抑制。高表达的miR-129-3p水平增加细胞侵袭能力,而增加CP110水平则降低细胞侵袭能力。在转移性前列腺癌细胞中过表达CP110导致转移数量减少。在前列腺癌患者组织中,低水平的CP110和高水平的miR-129-3p表达与转移相关,但与上皮-间质转化相关基因的表达无关。此外,在转移性前列腺癌细胞中过表达CP110导致过度中心体扩增(E-CA),以及F-肌动蛋白分布改变,这与其降低的转移能力一致。我们的数据表明,miR-129-3p通过维持促转移的中心体扩增(CA)并防止抗转移的E-CA,在转移性前列腺癌细胞中作为中心体扩增的守门人发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/f4e88ec7bed6/oncotarget-07-16676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/da4e03f7a591/oncotarget-07-16676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/fd3f53322b85/oncotarget-07-16676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/dff3146e8cc0/oncotarget-07-16676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/04073bb311d3/oncotarget-07-16676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/f4e88ec7bed6/oncotarget-07-16676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/da4e03f7a591/oncotarget-07-16676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/fd3f53322b85/oncotarget-07-16676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/dff3146e8cc0/oncotarget-07-16676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/04073bb311d3/oncotarget-07-16676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/4941343/f4e88ec7bed6/oncotarget-07-16676-g005.jpg

相似文献

1
miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.微小RNA-129-3p通过抑制CP110来控制转移性前列腺癌细胞中的中心体数量。
Oncotarget. 2016 Mar 29;7(13):16676-87. doi: 10.18632/oncotarget.7572.
2
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.致癌性 miR-210-3p 通过 NF-κB 信号通路促进前列腺癌细胞 EMT 和骨转移。
Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.
3
MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.微小RNA-129-3p通过抑制CP110促进乳腺癌细胞对多西他赛的耐药性。
Sci Rep. 2015 Oct 21;5:15424. doi: 10.1038/srep15424.
4
The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells.miRNAs 203a/210-3p/5001-5p 调节雄激素/雄激素受体/YAP 诱导的前列腺癌细胞迁移。
Cancer Med. 2024 Aug;13(16):e70106. doi: 10.1002/cam4.70106.
5
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.miR-141-3p 的下调通过激活 NF-κB 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2017 Dec 4;36(1):173. doi: 10.1186/s13046-017-0645-7.
6
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.miR-605-3p 通过上调 EZH2 抑制前列腺癌的恶性进展。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8795-8805. doi: 10.26355/eurrev_201910_19274.
7
Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT/mTOR pathway-mediated inhibition of autophagy.成骨细胞来源的外泌体miR-140-3p靶向ACER2,并通过AKT/mTOR通路介导的自噬抑制作用促进前列腺癌进展。
FASEB J. 2024 Dec 15;38(23):e70206. doi: 10.1096/fj.202401480R.
8
Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.Micro-RNA-186-5p 抑制可减弱转移性前列腺癌细胞的增殖、锚定非依赖性生长和侵袭。
BMC Cancer. 2018 Apr 13;18(1):421. doi: 10.1186/s12885-018-4258-0.
9
Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.鉴定与人类前列腺癌细胞转移潜力差异相关的相互作用 miRNA-mRNA 对,并进行信号通路分析。
J Cell Biochem. 2019 Oct;120(10):17779-17790. doi: 10.1002/jcb.29045. Epub 2019 May 24.
10
Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p/MYPT1/p-MLC2 axis in prostate cancer.新型环状 RNA circSOBP 通过调控 miR-141-3p/MYPT1/p-MLC2 轴影响前列腺癌细胞的阿米巴样运动。
Clin Transl Med. 2021 Mar;11(3):e360. doi: 10.1002/ctm2.360.

引用本文的文献

1
lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.长链非编码RNA XIST/微小RNA-129-2-3p轴靶向CCP110以调节子宫内膜癌细胞的增殖、侵袭和迁移。
Exp Ther Med. 2023 Feb 22;25(4):159. doi: 10.3892/etm.2023.11858. eCollection 2023 Apr.
2
Overcome cancer drug resistance by targeting epigenetic modifications of centrosome.通过靶向中心体的表观遗传修饰克服癌症耐药性。
Cancer Drug Resist. 2019 Jun 19;2(2):210-224. doi: 10.20517/cdr.2018.010. eCollection 2019.
3
Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 the sponge effect on miR-129-5p.

本文引用的文献

1
How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.如何擅长“为恶”:中心体扩增与有丝分裂倾向驱动肿瘤内异质性
Cancer Metastasis Rev. 2015 Dec;34(4):703-13. doi: 10.1007/s10555-015-9590-0.
2
Centrosomal AKAP350 and CIP4 act in concert to define the polarized localization of the centrosome and Golgi in migratory cells.中心体锚定蛋白 350(AKAP350)和细胞溶质分裂周期蛋白 4(CIP4)协同作用,以确定迁移细胞中心体和高尔基体的极化定位。
J Cell Sci. 2015 Sep 1;128(17):3277-89. doi: 10.1242/jcs.170878. Epub 2015 Jul 24.
3
Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes.
环状 RNA 卷曲螺旋结构域包含 66 个通过上调 La 核糖核蛋白 1 对 miR-129-5p 的海绵效应调节甲状腺乳头状癌的恶性发展。
Bioengineered. 2022 Mar;13(3):7181-7196. doi: 10.1080/21655979.2022.2036304.
4
MicroRNA miR-425 promotes tumor progression by inhibiting Dickkopf-related protein-3 in gastric cancer.微小 RNA miR-425 通过抑制胃癌中的 Dickkopf 相关蛋白-3 促进肿瘤进展。
Bioengineered. 2021 Dec;12(1):2045-2054. doi: 10.1080/21655979.2021.1930743.
5
MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2.MicroRNA-144 抑制 EZH2 靶向抑制前列腺癌生长和转移。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821989817. doi: 10.1177/1533033821989817.
6
Emerging roles of DYRK2 in cancer.DYRK2 在癌症中的新兴作用。
J Biol Chem. 2021 Jan-Jun;296:100233. doi: 10.1074/jbc.REV120.015217. Epub 2021 Jan 7.
7
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.中心体扩增:实体恶性肿瘤中具有预后价值的可量化癌细胞特征。
Cancer Metastasis Rev. 2021 Mar;40(1):319-339. doi: 10.1007/s10555-020-09937-z. Epub 2020 Oct 26.
8
MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3.微小RNA-425通过靶向Dickkopf 3促进膀胱癌的迁移和侵袭。
J Cancer. 2020 Mar 13;11(12):3424-3432. doi: 10.7150/jca.40233. eCollection 2020.
9
Effects of miR-129-3p on biological functions of prostate cancer cells through targeted regulation of Smad3.miR-129-3p通过靶向调控Smad3对前列腺癌细胞生物学功能的影响
Oncol Lett. 2020 Feb;19(2):1195-1202. doi: 10.3892/ol.2019.11216. Epub 2019 Dec 13.
10
MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.miR-129-5p 通过下调 CAMK2N1 表达促进前列腺癌多西他赛耐药。
J Cell Mol Med. 2020 Feb;24(3):2098-2108. doi: 10.1111/jcmm.14050. Epub 2019 Dec 26.
非模板化核苷酸添加区分了细胞与外泌体中的小RNA组成。
Cell Rep. 2014 Sep 25;8(6):1649-1658. doi: 10.1016/j.celrep.2014.08.027. Epub 2014 Sep 18.
4
PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells.PCTAIRE1使p27磷酸化并调节癌细胞的有丝分裂。
Cancer Res. 2014 Oct 15;74(20):5795-807. doi: 10.1158/0008-5472.CAN-14-0872. Epub 2014 Sep 9.
5
Aurora kinase A inhibitors: promising agents in antitumoral therapy.极光激酶A抑制剂:抗肿瘤治疗中有前景的药物。
Expert Opin Ther Targets. 2014 Dec;18(12):1377-93. doi: 10.1517/14728222.2014.956085. Epub 2014 Sep 9.
6
Excess centrosomes disrupt endothelial cell migration via centrosome scattering.过量中心体通过中心体离散破坏血管内皮细胞迁移。
J Cell Biol. 2014 Jul 21;206(2):257-72. doi: 10.1083/jcb.201311013.
7
miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110.miR-34/449 微 RNA 通过抑制 cp110 来促进游动纤毛的发生。
Nature. 2014 Jun 5;510(7503):115-20. doi: 10.1038/nature13413.
8
SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis.SKA1过表达促进中心粒过度复制、中心体扩增和前列腺肿瘤发生。
J Pathol. 2014 Oct;234(2):178-89. doi: 10.1002/path.4374. Epub 2014 Aug 4.
9
Cyclin B2 and p53 control proper timing of centrosome separation.细胞周期蛋白 B2 和 p53 控制着中心体分离的适当时机。
Nat Cell Biol. 2014 Jun;16(6):538-49. doi: 10.1038/ncb2952. Epub 2014 Apr 28.
10
Oncogene-like induction of cellular invasion from centrosome amplification.从中心体扩增诱导的癌基因样细胞侵袭。
Nature. 2014 Jun 5;510(7503):167-71. doi: 10.1038/nature13277. Epub 2014 Apr 13.